Announcements Trials
Browse Landscape

Phase

Phase 1 9Phase 2 4Phase 1/2 3

Status

Terminated 2Withdrawn 1

Sponsor Class

INDUSTRY 4OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Lymphoma 1Lung Neoplasms 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 154Carboplatin 146Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 118Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × belinostat × Clear all
NCT01188707 2020-10-19

A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer

Herlev Hospital

Phase 1/2 Terminated
5 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01090830 2018-02-23

HCH003

Holy Cross Hospital, Florida

Phase 1/2 Terminated
7 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02701673 2016-05-04

Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡